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Objectives
Lower limb muscle power is thought to influence outcome following total knee replacement 
(TKR). Post-operative deficits in muscle strength are commonly reported, although not 
explained. We hypothesised that post-operative recovery of lower limb muscle power would 
be influenced by the number of satellite cells in the quadriceps muscle at time of surgery. 
Methods
Biopsies were obtained from 29 patients undergoing TKR. Power output was assessed pre-
operatively and at six and 26 weeks post-operatively with a Leg Extensor Power Rig and data 
were scaled for body weight. Satellite cell content was assessed in two separate analyses, the 
first cohort (n = 18) using immunohistochemistry and the second (n = 11) by a new 
quantitative polymerase chain reaction (q-PCR) protocol for Pax-7 (generic satellite cell 
marker) and Neural Cell Adhesion Molecule (NCAM; marker of activated cells).
Results
A significant improvement in power output was observed post-operatively with a mean 
improvement of 19.7 W (95% confidence interval (CI) 14.43 to 30.07; p < 0.001) in the first 
cohort and 27.5 W (95% CI 13.2 to 41.9; p = 0.002) in the second. A strong correlation was 
noted between satellite cell number (immunohistochemistry) and improvement in patient 
power output (r = 0.64, p = 0.008). Strong correlation was also observed between the 
expression of Pax-7 and power output (r = 0.79, p = 0.004), and the expression of NCAM and 
power output (r = 0.84, p = 0.001). The generic marker explained 58% of the variation in 
power output, and the marker of activated cells 67%.
Conclusions
Muscle satellite cell content may determine improvement in lower limb power generation 
(and thus function) following TKR.
Article focus
 Although a highly successful procedure,
a number of patients report suboptimal
physical function following total knee
replacement (TKR). Loss of muscle
function compared with healthy age-
matched controls has been well
demonstrated, but simple models of
muscle atrophy have not satisfactorily
explained this
 We hypothesised that the intrinsic
ability of the patient’s musculature to
regenerate would influence physical
recovery, with the variation in
recovered muscle power influenced by
the underlying number of muscle
satellite cells
Key messages
 Variation in muscle satellite cell content of
the quadriceps muscle was found
between TKR patients using separate
immunohistochemistry and molecular
techniques to identify the cells
 Variation in satellite cell content
accounted for much of the variance of the
change in the patient’s physical perfor-
mance in the early post-operative period,
ten-times the variance explained by mea-
sures of pre-operative muscle power
Freely available online
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Strengths and limitations
 This is the first assessment as to the impact of muscle
satellite cell content to physical recovery following
TKR
 A particular strength of this paper is the linking of
molecular mechanisms with resultant function in a
clinical population
 A limitation of this analysis is that a single muscle
biopsy was taken at the time of surgery, thus any
change in the patients satellite cell content with
recovery could not be assessed. We suggest this as a
focus of future investigation
Introduction
The mechanisms involved in the regulation of skeletal
muscle growth and regeneration are of great interest, as it
is believed that these may be manipulated to improve the
quality of life of individuals suffering from conditions as
diverse as muscular dystrophy, chronic heart failure and
sarcopenia.1 In the field of orthopaedics, improved
regeneration of skeletal muscle would also have direct
and tangible benefits through enhanced patient outcome
following surgery; to date this has not been investigated.
A large patient population who may benefit from
advances in muscle regeneration are those undergoing
total knee replacement (TKR), as quadriceps muscle func-
tion is recognised as paramount to subsequent rehabilita-
tion and eventual outcome.2 Though a highly successful
procedure, some TKR patients report suboptimal func-
tion post-operatively.3,4 It is known that lower limb power
affects physical functioning following knee arthroplasty,5
and clinically it has been reported that pre-operative
physical ability is relevant to post-operative physical out-
come.6-8 Quadriceps muscle weakness is often reported
following surgery of the knee, and deficits of up to 30%
(compared with age-matched controls) have been dem-
onstrated in TKR patients.9 Muscle atrophy alone is not
able to explain this discrepancy.10 An inability to activate
the quadriceps muscle completely has been postulated as
a focal cause of chronic quadriceps weakness after TKR,10
but convincing data is lacking. No consideration has been
given to the mechanisms by which the muscle recovers
post-operatively, or its ‘regenerative potential’.
Studitsky11 in 1964 reported that a muscle removed,
minced and then returned to its original site was able to
regenerate into a functional muscle, a capacity attribut-
able to the muscle satellite cell.12 However, Jones and
Round13 note a widespread belief that muscle is not able
to regenerate following injury. The satellite cell is an
undifferentiated myogenic precursor, which sits quies-
cently under the basal lamina and proliferates following
injury to repair the damaged muscle fibre.14 In normal
muscle these cells respond to regenerative cues such as
injury or exercise to provide new myonuclei for the
homeostasis, hypertrophy or repair of muscle fibres.
Importantly, these cells also self-renew in order to
maintain a viable ‘stem-cell’ pool that is able to respond
to repeated demand.13,15 It has been suggested that the
number of satellite cells in an individual is variable and
factors such as ageing16-18 and history of exercise19-21 can
affect this number.
The regulation of satellite cell proliferation and differ-
entiation is not completely understood. The Pax7 gene is
considered to regulate the entry of quiescent satellite cells
into the myogenic programme and the neural cell adhe-
sion molecule (NCAM) is associated with activated cells.
In the few human studies conducted, immunohistochem-
ical antibody staining against either Pax7 or NCAM has
been used to identify the cells.16-20 Molecular assessment
of muscle satellite cells using quantitative polymerase
chain reaction (qPCR) to quantify Pax7 and NCAM mark-
ers has not been described.
It was hypothesised that the differing levels of recovery
of muscle power would be influenced by the number of
satellite cells in the quadriceps muscle. In addition our
secondary objective was to develop a quantitative molec-
ular method by which to assess satellite cell content in a
muscle sample.
Materials and Methods
Patient recruitment. A pragmatic trial design was
adopted through which we invited consecutive patients
who had been listed for TKR from the clinics of a single
orthopaedic surgeon (PG) to take part in the study. Inclu-
sion criteria were TKR for osteoarthritis and the ability to
provide informed consent. Exclusion criteria were the
presence of comorbidities that would affect post-opera-
tive recovery or subsequent physical performance, such
as cardiovascular or neurological disease, and failure to
meet the inclusion criteria. Patients were recruited over a
single calendar year. Of 54 patients, 29 met the inclusion
criteria and agreed to participate. Two patients were sub-
sequently withdrawn with medical complications follow-
ing surgery that prohibited functional evaluation,
although their muscle samples are included in the analy-
sis. Local ethical approval was granted by the Lothian
Research Ethics Committee.
Power output assessment. Specific evaluation of the
recovery of muscle strength was assessed by use of a Leg
Extensor Power Rig (Queens Medical Centre, Notting-
ham, United Kingdom), which has been validated with
this population group.5,22,23 The apparatus consists of a
seat and footplate connected via a lever and chain to a fly-
wheel. Application of force accelerates the flywheel from
rest, and output is recorded as both maximal wattage (W)
generated and as relative power–bodyweight ratio (%) of
a single leg extension. The test procedure was conducted
as per the manufacturer’s instructions. The highest
recorded output was used for analysis.24 Those not able
to complete the test were assigned a score of zero.5 Body
weight (kg) was measured separately at each time point
using a calibrated set of mechanical medical grade floor
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scales (SECA, Hamburg, Germany). Baseline power out-
put was determined pre-operatively and then subse-
quently at routine clinical review at six and 26 weeks
post-operatively.
Muscle sampling. A muscle sample was obtained from the
distal quadriceps during the surgical procedure via the sur-
geon’s routine incision. The sample site was standardised.
The biopsy was obtained 5 cm proximal to the superior
pole of the patella, dependent on the tissue quality of the
individual. The initial 18 samples were immediately fixed in
10% neutral buffered formalin (4% formaldehyde in phos-
phate buffered saline) and kept in a fridge for 24 hours,
before subsequent immersion in 70% ethanol and embed-
ding in paraffin wax for immunohistological analysis. The
11 further muscle samples were immediately snap frozen
in liquid nitrogen before immersion in RNAlater ice
(Ambion, Austin, Texas) to preserve the RNA and stored at
-80°C for qPCR analysis. An additional control biopsy of
quadriceps was obtained from a similar site in the muscle
of a healthy young adult patient aged 22 years undergoing
surgery to equalise limb lengths.
Immunohistochemistry. Biopsies that had been wax
embedded underwent a standard de-waxing protocol,
using xylene and graded ethanol baths before antigen
retrieval using sodium citrate. Sections were loaded onto
sequenza plates and washed in phosphate buffered saline
(PBS; without calcium and magnesium) before adding
three drops Protein Block (AMS biotechnology,
Abingdon-on-Thames, United Kingdom) solution for
30 minutes at room temperature. Primary mouse anti-
human Pax7 antibodies (Abcam, Cambridge, United
Kingdom) were diluted (1:150) in the protein block solu-
tion and 250 μl was added to each slide for one hour at
room temperature. The slides were washed three times in
PBS, and 1:500 diluted Alexa Fluor goat anti-mouse
488 (Invitrogen, Paisley, United Kingdom) secondary
antibody added for 30 minutes at room temperature in
the dark. The slides received a further four washes in PBS
before dehydrating them in 100% ethanol and air drying.
The slides were then mounted with vectashield hardest
mounting medium with DAPI for fluorescence (Vector
laboratories, Peterborough, United Kingdom). In order to
ensure antibody-specific staining, a control experiment
was run in parallel that followed the exact protocol,
excluding the primary antibody. Positive cells were iden-
tified on the basis of immunofluorescent staining in asso-
ciation with nuclear material, and confirmed by their
position under the basal lamina (Fig. 1a). Positive cells
superficial to the basal lamina were not counted.
Imaging and cell counting. Images of the sections were
captured on a Zeiss Axioscope II MOT (Zeiss, Oberkochen,
Germany) compound microscope under a 20 × objective
equipped with a Hamamatsu Camera Controller ORCA-
ERE (Hamamatsu Corp., Hamamatsu, Japan) and Open-
Lab 4.0 image analysis software (ImproVision, Coventry,
United Kingdom). Fluorescent images were then merged
using Photoshop (Adobe Systems, San Jose, California).
Positive identification of satellite cells was determined by
immunofluorescent staining in association with nuclear
material, and by position under the basal lamina. Three
separate areas of each section were imaged. In each
image, the number of muscle fibres, satellite cells and
myonuclei were counted, and an average of three cell
counts per section were used for analysis. The positive
staining index (PSI) was calculated (no. of satellite cells/
total no. of myonuclei × 100). Cell counting was per-
formed by a single individual blinded to the patient iden-
tity until the analysis was complete. 
RNA extraction and cDNA production. Before RNA extrac-
tion the 12 samples were thawed at -20°C for 24 hrs.
Whole muscle tissue was homogenised and RNA was
extracted using nucleospin columns (Macheray Nagel,
Duren, Germany) according to the kit protocol. The RNA
yielded was quantified by nanodrop spectrophotometer
(Thermoscientific, Beverley, Massachusetts) and cDNA
was produced using a high capacity cDNA reverse tran-
scription kit (Applied Biosystems, Foster City, California)
following the kit protocol for q-PCR analysis.
Quantitative-PCR analysis. Intron spanning primers
were designed for the satellite cell markers Pax7
(Forward primer 5′gggattccctttggaagtgt3′, Reverse
primer 5′cgcccattgatgaagacc3′) and NCAM (Forward
primer 5′aagacgcagccagtccaa3′, Reverse primer
5′tgcttgatcaggttcactttaataga3′). An 18S (ribosomal RNA)
primer was used as the housekeeping gene: RT-PCR 18S
control kit (Eurogentec, Liege, Belgium). In order to
quantify gene expression in human muscle tissue, each
reaction contained 10 μl of Syber Green (iTaq SYBR
Green Supermix with rox (BioRad, Hertfordshire, United
Kingdom)) 7 μl of water, 1 μl of forward primer, 1 μl of
reverse primer (Eurogentec) added to 1 μl of cDNA. This
was loaded in duplicate wells on q-PCR plates (Applied
Biosystems) for each sample and run on a 7500 Fast
Real-time PCR machine (Applied Biosystems). The fol-
lowing PCR cycling conditions were used for amplifica-
tion: 50˚C 2 min, 95˚C 10 min, then 40 cycles of 95°C
15 s and 60°C 1 min. A dissociation step of 95°C for 15 s,
60°C for 1 min and 95°C for 15 s was performed at the
same time to check for primer specificity and ensure that
false positive products were not generated during the
amplification. Pax7 and NCAM were normalised to the
level of the 18S housekeeping control gene and quanti-
fication of each gene was performed using the 2-ΔΔcT cal-
culation and expressed relative to the control sample
from a young patient who had healthy muscle tissue.
This allowed quantification of the content of the satellite
cell markers expressed in individual arthroplasty
patients against an artificial ‘zero’ obtained from a
young healthy control.
Statistical analysis. Data were assessed with the Minitab
v15 (Minitab Inc., State College, Pennsylvania) software.
All data was assessed visually for normality. Differences
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in power outcome scores were assessed by paired
sample t-tests. Correlation between patient power out-
put and muscle satellite cell number was assessed with
the Pearson product moment correlation coefficient and
uni-variant linear regression performed to quantify this
association. A p-value < 0.05 was considered to indicate
statistical significance.
Results
The first cohort (n = 18) was examined using immuno-
chemistry: there were seven male and 11 female patients
with a mean age of 73.56 years (62 to 84). The second
cohort (n = 11) was examined by molecular methods:
there were four male and seven female patients with a
mean age of 72.34 years (68 to 79).
Identification of satellite cells by immunohistochemistry.
Of the initial 18 muscle samples, 17 were found to con-
tain viable muscle tissue by haematoxylin & eosin stain-
ing (data not shown). In the control sections where only
secondary antibodies were used, no cells were detected,
thus demonstrating that there was no non-specific stain-
ing of the antibody. 
The variation of satellite cell number was observed
within the patient population (Table I, Fig. 1). The posi-
tive staining index (PSI) of muscle satellite cells was calcu-
lated by assessing three separate areas of each individual
section. The satellite cell data was normally distributed,
with a mean PSI of 7.62 (95% confidence interval (CI)
6.30 to 8.94) satellite cells per sample. The mean PSI var-
ied between patients from 3.07 to 11.35.
Fig. 1c
Histological images showing the identification of muscle satellite cells by immunofluorescence. Satellite cells are marked with Pax7 antibody (green) and myo-
nuclei with DAPI (blue). In cases where the final image confirmed the presence of a Pax7 positive cell and DAPI, but location under the sarcolemma was in ques-
tion, care was taken to examine the muscle architecture, and cells superficial to the basal lamina were not counted.
Fig. 1d
Fig. 1a Fig. 1b
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Power output. Wide variation in power output between
individual patients was observed (Table II). Significant
improvement (paired samples t-test) in mean power out-
put of 19.7 W (95% CI 14.43 to 30.07; p < 0.0001), was
observed between assessments at six and 26 weeks,
reflecting an improvement of 27% (95% CI 0.15 to 0.38;
p < 0.0001) in power-body weight ratio. Non-significant
improvement was observed between measurements pre-
operatively and at six weeks (p = 0.08).
Relationship between satellite cell content and power
output. A strong correlation was noted between the sat-
ellite cell PSI and improvement in patient power output
both in terms of maximal power output (r = 0.57,
p = 0.023) and power-body weight ratio (r = 0.64,
p = 0.008) (Fig. 2). Uni-variant regression (R2) demon-
strated that 27% of the variation in improved maximal
power output could be attributed to the variation in the
number of underlying satellite cells. Furthermore, 37% of
the variation could be attributed to the satellite cell num-
ber (PSI) when power output was scaled for bodyweight.
This compares with the relationship of post-operative
change in power output with patient age (7%), and with
pre-operative power output (3.5%).
Patient satellite cell profile by quantitative PCR.
Despite identifying satellite cells by immunofluorescence,
we wanted to further investigate the status of satellite
cells in arthroplasty patients by measuring gene expres-
sion of Pax7 and NCAM. We included a younger healthy
control patient in this experiment to act as a standard for
the mRNA expression levels of these genes thus giving us
some insight into the activity of the satellite cells in
arthroplasty patients. Wide variation in Pax7 gene expres-
sion was found between arthroplasty patients, with 80%
of the group having ≤ 50% Pax7 than the healthy control.
Similarly there was a difference in the amount of activated
satellite cell (NCAM) mRNA expressed in each patient;
interestingly 60% of the arthroplasty group had NCAM
expression equal to or higher than the control (Table III).
No gene expression was recorded for sample 25 and no
expression of NCAM was found in sample 30.
Power output. Again wide variation in power output
between individual patients in this q-PCR cohort was
observed (Table II). Significant improvement in mean
power output of 27.5 W (95% CI 13.2 to 41.9; p = 0.002)
was observed between the six- and 26-week assessments.
This reflected a mean improvement of 29% (95% CI 20 to
40; p < 0.0001) in power-bodyweight ratio, the same per-
centage improvement as the immunohistochemical
cohort.
Relationship between satellite cell content and power
output. Strong correlation was observed between the
expression of the generic satellite cell marker Pax-7 and
both the change in maximal lower limb power output
(r = 0.58, p = 0.06), and power-body weight ratio
(r = 0.79, p = 0.004) (Fig. 3). Particularly strong correla-
tion was observed between the relative expression of acti-
vated satellite cell marker (NCAM) and the both the
change in the patients maximal power output (r = 0.83,
p = 0.002) and power-bodyweight ratio (r = 0.84,
p = 0.001) (Fig. 3).
Uni-variant regression demonstrated 26% of the
variation in improved maximal power output could be
Table I. Satellite cell count on immunohistochemical analysis.
Data were calculated and averaged from three imaged regions
per muscle section/individual patient (PSI, positive staining
index)
Sample
Mean satellite 
cell count Myonuclei PSI
1* - - -
2 5.34 105 5.09
3 13 108.34 11.99
4 9.67 104.67 9.24
5 8.4 101.67 8.26
6 12.25 123.34 9.93
7 9.25 104.5 8.85
8 8 82.67 9.68
9 8.67 104.34 8.31
10 4 130.34 3.07
11 10.67 94 11.35
12 7.34 104.34 7.04
13 5 107.67 4.64
14 11 98.25 11.20
15 5.67 136.24 4.16
16 5.67 100.34 5.65
17 9.5 135 7.04
18 10.67 158.67 6.73
* sample 1 was found to contain no viable muscle and was
therefore not included
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attributed to the variation in the expression of the Pax-7
gene in the muscle samples, which increased to 58%
when scaled for power-bodyweight ratio. Separately,
65% of the improvement in maximal power could be
attributed to the variation in the expression of the NCAM
gene in the muscle samples, 67% when scaled for power-
bodyweight ratio.
Discussion
This is the first study to assess the influence of the muscle
satellite cell on a patient’s physical recovery following
TKR. There are three notable findings of this analysis. First,
that variation in satellite cell content was found among
the patient samples. Secondly, it was found that the
intrinsic cell number in the patient’s quadriceps muscle
accounted for much of the variance in physical perfor-
mance post-operatively. Thirdly, that a stronger correla-
tion with power output was observed with the marker of
activated cells (NCAM) than with the generic satellite cell
marker (Pax-7). 
The immunofluorescence staining demonstrated that
the number of satellite cells accounted for a third of the
change in power output post-operatively, explaining
around ten times more of the variance in post-operative
power output compared with the patient’s pre-operative
ability, which is commonly perceived to be a relevant
factor.4-6 This association between satellite cells and post-
operative recovery of muscle power was confirmed in the
separate cohort of 11 patients, analysed with quantitative-
PCR, which assessed the mRNA expression of satellite cell
markers. This is the first example of such a technique being
employed to measure Pax7 and NCAM in human samples.
The vast majority of muscle satellite cell research has been
conducted in murine models, with only a handful of
authors conducting human studies. Boldrin, Muntoni and
Morgan25 commented upon equivocal and sometimes
Table II. Power output (qPCR, quantitative polymerase chain reaction)
Maximal power output (W) Power–body weight ratio (%)
Sample* Pre-
operative Six weeks 26 weeks
Change
from six to 
26 weeks
Pre-
operative Six weeks 26 weeks
Change 
from six to
26 weeks
Immunohistochemistry
1 30 33 41 8 0.4 0.5 0.6 0.1
2 18 72 74 2 0.2 1.0 1.0 0.0
3 116 104 134 18 1.1 1.0 1.2 0.2
4 33 69 103 24 0.3 0.7 1.0 0.3
5 73 60 103 43 0.8 0.8 1.3 0.5
6 1 35 55 20 0.0 0.4 1.0 0.6
7 2 8 36 28 0.0 0.1 0.4 0.3
8 - - - - - - - -
9 137 148 189 41 1.8 2.0 2.4 0.4
10 97 86 84 -2 0.6 0.8 0.7 -0.1
11 59 46 65 20 1.1 0.7 1.2 0.5
12 38 70 72 2 0.5 1.1 1.1 0.0
13 4 20 28 8 0.1 0.3 0.4 0.1
14 13 65 92 33 0.2 0.9 1.2 0.3
15 3 1 38 33 0.2 0.9 1.2 0.3
16 - - - - - - - -
17 144 115 149 34 1.5 1.2 1.5 0.3
18 3 31 56 25 0.0 0.5 0.7 0.2
Mean (SE) 48.2 (12.6) 60.2 (10.0) 82.4 (11.2) 21.1 (3.5) 0.55 (0.14) 0.81 (0.11) 1.06 (0.12) 0.25 (0.05)
q-PCR
20 39 66 135 69 0.3 0.6 1.1 0.5
21 10 37 53 15 0.2 0.7 0.9 0.2
22 72 66 121 55 0.7 0.6 1.1 0.5
23 14 33 58 25 0.2 0.4 0.8 0.4
24 19 23 43 20 0.3 0.3 0.6 0.3
25 30 37 49 12 0.3 0.4 0.6 0.2
26 14 17 38 21 0.3 0.3 0.6 0.3
27 44 83 107 24 0.5 1 1.2 0.2
28 0 18 21 3 0 0.4 0.4 0
29 1 6 57 51 0 0.1 0.6 0.5
30 0 7 14 7 0 0.1 0.2 0.1
Mean (SE) 22.1 (6.76) 35.7 (7.8) 63.3 (12.1) 27.5 (6.4) 0.26 (0.07) 0.45 (0.08) 0.74 (0.9) 0.29 (0.05)
* patients 8 and 16 were excluded from the power analysis due to medical complications following surgery that prohibited provision of this data. Patient
19 was the control specimen, and is therefore not represented in the table
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contradictory reports on numbers of satellite cells in
human muscle sections. However, q-PCR addresses this
issue by quantifying the genetic material present in the
whole sample as opposed to imaging markers on sections.
An additional benefit of this analysis is that both the
generic marker (Pax7) and activated cell marker (NCAM)
could be assessed at the same time.
The expression of the generic marker was able to
explain around 50% of the variation of the change in
post-operative power output, while the activated cell
marker was found to account for two thirds of the
change. Two samples did not express cell markers in the
qPCR experiment, which is probably as a result of tissue
degradation. The time taken from muscle biopsy in the-
atre to immersing the sample in liquid nitrogen in the
theatre anteroom was generally less than one minute, but
in these cases the time was notably longer, at around five
minutes. It may be that this time frame is crucial for sub-
sequent RNA expression.
Previous large studies have shown a relationship
between muscle power and post-operative function.6,7 It
has been demonstrated that muscle power correlates
more strongly than muscle strength to physical function,
as power involves both force production and contraction
velocity, which better reflects daily tasks that are force and
speed dependant.26-28 Improvement in muscle power
output has been reported at six months after TKR,5 and
the current study supports this, also demonstrating an
improved mean muscle power between assessments.
Magnitude of power output is inherently associated with
the individual’s underlying muscle mass, as every muscle
fibre can be thought of as an independent force
generating unit.11 For this reason, measurement of the
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Fig. 2
Scatter graph showing the positive staining index (PSI) of satellite
cells and post-operative change in power output in the cohort
examined with immunohistochemistry.
Table III. mRNA expression of Pax-7 and Neural Cell Adhesion Molecule (N-CAM) relative to the control sample by
qualitative polymerase chain reaction (q-PCR)
Sample
Control (19) 20 21 22 23 24 25 26 27 28 29 30
N-CAM 1 1.81 0.91 2.22 0.69 0.50 0.00 1.25 0.87 0.00 0.95 0.00
Pax-7 1 0.47 0.32 1.45 0.76 0.47 0.00 0.22 0.61 0.14 0.26 0.16
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Fig. 3
Scatter graph showing the satellite cell volume by expression of
cell marker and post-operative change in power output in the
cohort examined with quantitative polymerase chain reaction (q-
PCR) (NCAM, Neural Cell Adhesion Molecule).
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improvement in power was assessed both in terms of
absolute power and ratio of power relative to body-
weight. The power to bodyweight figure takes into
account the general size of the individual, and is therefore
the more relevant of the two measures for assessing
change expressed in the population.
Pain (attributable to OA) is the prime indication for
undergoing arthroplasty of the knee, and reduction of
this pain the major goal of surgery. It is likely that high
pre-operative pain level prevents accurate measurement
of power output at this time, through limitation of the
patients’ ability to generate force by pain inhibition path-
ways. Patients typically reported much alleviation of pain
by the time of the six-week review, and all individuals
were all able to mobilise at this stage without the use of
the aids required in the early post-operative phase. It is
thus consistent that the change in power output between
six and 26 weeks was the correlated with the underlying
cell content.
Mizner et al10 reported a reduction of quadriceps
strength in the first three to four weeks post-operatively
compared with pre-operative levels in a small TKR
cohort. They suggested that a combination of muscle
atrophy and failure of voluntary muscle activation
explained 85% of the loss of quadriceps strength, but
that the failure of activation was the dominant factor,
explaining twice as much of the variance as the muscle
atrophy. This failure of neuromuscular activation in the
early post-operative phase is an attractive explanation of
the poor levels of quadriceps strength and power
reported in the first month post-operatively, however
this does not explain prolonged power and strength def-
icits.9,29 Krishnan and Williams30 investigated chronic
weakness following ACL reconstruction and found that
this was not associated with failure of voluntary activa-
tion, instead peripheral changes in the muscle relating
perhaps to chronic atrophy accounted for the prolonged
weakness. No correlation was found in the present study
between satellite cell number and power output at the
six-week assessment (broadly around the same time
point as the Mizner study10). It is possible that neuro-
muscular function deficits were important in the imme-
diate post-operative period, whereas regenerative
potential and satellite cell content may be relevant in the
medium to longer term.
This is the first study to report the variation in the individ-
uals’ satellite cell numbers in an osteoarthritic population,
which was found to be similar to that in the wider popula-
tion.16-18 The process of osteoarthritis is not known to
affect the number of individual satellite cells. However,
Charifi et al19 have demonstrated a preservation of the sat-
ellite cell pool in elderly subjects that engaged in regular
exercise and as patients with osteoarthritis are likely to
exercise less, they may have less well preserved satellite cell
pools. This may then limit muscle regeneration post-
operatively, and subsequently physical function.
In conclusion, pre-operative lower limb power (and
thus patient function) was found to be less predictive of
physical muscle power recovery post-TKR than the
number of satellite cells within the quadriceps muscle.
Ten times the variation of change in power output post-
operatively was linked to the underlying number of mus-
cle satellite cells in the individual compared with a mea-
sure of pre-operative power output. It was further found
that the expression of the marker of the satellite cells that
were activated, was even more strongly correlated with
the change in post-operative lower limb power output,
and explains around two thirds of the variation in change
in post-operative power output.
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